Related Experiment Video
Updated: Oct 1, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Successful planned pregnancy in a patient with St Jude medical prosthetic mitral valve
Tsuyoshi Fukuda1, Tatsuo Yokoyama, Masaki Otaki
1Division of Pediatric Cardiology, Kinki University School of Medicine, Osaka, Japan. fukuda@kpcd.med.kindai.ac.jp
A primiparous woman with a St Jude Medical (SJM) mitral valve prosthesis and receiving anticoagulant drug delivered a healthy male infant by spontaneous normal vaginal delivery. Oral warfarin was replaced by subcutaneous heparin at the 6th week of gestation and the dosage of heparin was adjusted to maintain a partial thromboplastin time between 2.0 and 2.5 times the control value. Treatment with heparin was administered during the first trimester and the last 5 weeks of gestation. Warfarin was used between the 13th and 32nd week. Successful pregnancy and delivery in patients with a SJM mitral valve prostheses is possible with careful maintenance of anticoagulation.
A primiparous woman with a St Jude Medical (SJM) mitral valve prosthesis and receiving anticoagulant drug delivered a healthy male infant by spontaneous normal vaginal delivery. Oral warfarin was replaced by subcutaneous heparin at the 6th week of gestation and the dosage of heparin was adjusted to maintain a partial thromboplastin time between 2.0 and 2.5 times the control value. Treatment with heparin was administered during the first trimester and the last 5 weeks of gestation. Warfarin was used between the 13th and 32nd week. Successful pregnancy and delivery in patients with a SJM mitral valve prostheses is possible with careful maintenance of anticoagulation.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse III: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction

